Tuesday, May 29, 2012 11:25:25 AM
I can't guess how close partenrship news is, there are approval steps regarding mast-out that can be predicted as regards to timing, such as Effectiveness complete step. But overall approval timing can't be predicted.
Recent ICCC News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2026 09:07:25 PM
- ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025 • GlobeNewswire Inc. • 03/04/2026 09:05:00 PM
- ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025 • GlobeNewswire Inc. • 02/18/2026 01:37:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 09:07:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2026 10:22:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2026 04:43:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2026 09:13:10 PM
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025 • GlobeNewswire Inc. • 01/08/2026 09:05:00 PM
- ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus • GlobeNewswire Inc. • 01/07/2026 01:10:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2025 01:00:08 PM
- ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain® • GlobeNewswire Inc. • 12/24/2025 06:05:00 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 12/04/2025 09:11:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/03/2025 09:14:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2025 01:12:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 09:08:17 PM
- ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025 • GlobeNewswire Inc. • 11/13/2025 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/12/2025 01:43:06 PM
- ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025 • GlobeNewswire Inc. • 11/06/2025 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2025 09:08:55 PM
- ImmuCell Announces Onboarding of New CEO and Related Management Changes • GlobeNewswire Inc. • 11/04/2025 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2025 08:06:05 PM
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025 • GlobeNewswire Inc. • 10/07/2025 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2025 08:05:23 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
